skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines donanemabQuestion & answer

donanemab · Medicine question

Can it be used for moderate or advanced Alzheimer’s disease?

iatroX medicinesPublished 20 August 2026Reviewed 20 August 2026

The answer

Answer

No. The UK licence is limited to mild cognitive impairment and mild dementia due to Alzheimer’s disease.

Sources for this answer

Kisunla 350 mg concentrate for solution for infusionemc · SmPC Current selected SmPC · Version 3

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

donanemab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the donanemab guide

More questions about donanemab

Does donanemab cure Alzheimer’s disease?Why are ApoE4 testing and MRI scans needed?What is ARIA?Can donanemab be used with blood thinners?What should emergency clinicians know?

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX